rTMS for Depression After Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
This trial is testing a new treatment for depression called rTMS in people who have spinal cord injuries. rTMS uses magnets to stimulate the brain. The study will check if this treatment is safe and if it helps reduce depression symptoms. Repetitive transcranial magnetic stimulation (rTMS) has been researched for over 15 years and is considered an effective treatment for depression.
Will I have to stop taking my current medications?
The trial requires that you have not changed your antidepressant or psychotropic medication doses for at least 4 weeks before starting, or 6 weeks if you recently started a new medication. If you meet this condition, you may not need to stop your current medications.
What data supports the effectiveness of the treatment rTMS for depression after spinal cord injury?
Research shows that repetitive transcranial magnetic stimulation (rTMS) can help improve motor function, reduce spasticity (muscle stiffness), and modulate nerve pathways in people with spinal cord injuries. While these studies focus on physical recovery, they suggest that rTMS may have potential benefits for other conditions like depression by influencing brain activity.12345
Is rTMS safe for humans?
Repetitive transcranial magnetic stimulation (rTMS) has been studied for safety in humans, including those with depression, and generally shows a good safety profile. Studies have examined its use over several weeks, indicating it is safe for short-term use, but more research is needed to fully understand its long-term safety, especially in people with spinal cord injuries.12356
How is rTMS treatment different from other treatments for depression after spinal cord injury?
rTMS (repetitive transcranial magnetic stimulation) is unique because it uses magnetic fields to non-invasively stimulate specific areas of the brain, potentially improving sensory, motor, and autonomic functions after spinal cord injury. Unlike traditional drug treatments, rTMS directly targets brain activity, which may help with recovery of function and reduction of spasticity.12347
Research Team
Catherine VanDerwerker, DPT, PhD
Principal Investigator
Medical University of South Carolina
Eligibility Criteria
This trial is for individuals aged 18-70 who have had a spinal cord injury at the cervical or thoracic level for over 6 months and are experiencing depression. They must be able to move their right thumb, not have started new psychotropic meds in the last 4-6 weeks, and cannot be pregnant or have certain neurological conditions.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive rTMS treatment five days a week for four weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- rTMS (Non-invasive Brain Stimulation)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
The Craig H. Neilsen Foundation
Collaborator